Doxycycline Bests Azithromycin for Anogenital Chlamydia in Women
(MedPage Today) -- Doxycycline was superior to azithromycin for women with both anorectal and vaginal Chlamydia trachomatis infections, French researchers found in an open-label randomized trial. In a modified intention-to-treat analysis, microbiological... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - May 10, 2022 Category: Infectious Diseases Source Type: news

azithromycin (Zithromax): For COVID-19
Title: azithromycin (Zithromax): For COVID-19Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 4/4/2022 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - April 4, 2022 Category: Drugs & Pharmacology Source Type: news

Essential medicines to get expensive by more than 10 per cent from April
The NLEM list includes drugs like paracetamol, antibiotics like azithromycin, used to treat bacterial infections, anti-anaemia, vitamins and minerals. Some drugs used for treating moderately to severely ill Covid-19 patients and steroids are also included in the list. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 25, 2022 Category: Pharmaceuticals Source Type: news

Essential medicines to get expensive from April
The NLEM list includes drugs like paracetamol, antibiotics like azithromycin, used to treat bacterial infections, anti-anaemia, vitamins and minerals. Some drugs used for treating moderately to severely ill Covid-19 patients and steroids are also included in the list. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 25, 2022 Category: Pharmaceuticals Source Type: news

Azithromycin Therapy Does Not Reduce Recurrent Wheeze After RSV
MONDAY, March 14, 2022 -- Azithromycin therapy during acute severe respiratory syncytial virus (RSV) bronchiolitis does not reduce recurrent wheeze over two to four years, according to a study published online Feb. 27 in NEJM Evidence. Avraham... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 14, 2022 Category: Pharmaceuticals Source Type: news

Azithromycin Doesn't Prevent Wheezing After Acute Infant RSV Azithromycin Doesn't Prevent Wheezing After Acute Infant RSV
Azithromycin administered for severe early-life respiratory syncytial virus bronchiolitis did not prevent recurrent wheezing in affected children over the next 2-4 years.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 2, 2022 Category: Consumer Health News Tags: Pediatrics News Source Type: news

Alembic Pharma net profit drops 40% to Rs 176 crore in Q3FY22
"India business is going to grow, and continue to grow faster than our represented market, the initiatives we have taken in last few years and the Omicron coming up in the last quarter - some of the COVID related therapies like Azithromycin have seen sharp uptake in January," Pranav Amin, managing director, international business at Alembic Pharma told ET. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 10, 2022 Category: Pharmaceuticals Source Type: news

Antibiotics for the treatment of COVID19, Cochrane Database of Systematic Reviews
Review of 11 studies (n=11,281) found evidence of high certainty that azithromycin does not reduce risk of death in hospitalised COVID ‐19 patients and of moderate certainty that it does not attenuate clinical worsening or improvement. There is no evidence for other antibiotics. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 3, 2022 Category: Consumer Health News Source Type: news

Antibiotics for the treatment of COVID19, Cochrane Library
Main results We included 11 studies with 11,281 participants with an average age of 54 years investigating antibiotics compared to placebo, standard of care alone or another antibiotic. No study was found comparing antibiotics to an intervention with proven efficacy. All studies investigated azithromycin, two studies investigated other antibiotics compared to azithromycin. Seven studies investigated inpatients with moderate to severe COVID ‐19 and four investigated mild COVID‐19 cases in outpatient settings. Eight studies had an open‐label design, two were blinded with a placebo control, and one did not report on bli...
Source: Current Awareness Service for Health (CASH) - November 22, 2021 Category: Consumer Health News Source Type: news

Hydroxychloroquine sales spiked almost 100% in Australia at start of Covid pandemic, study finds
There was also a rise in prescriptions for ivermectin being filled, despite no evidence either drug is effective against the virusThe amount of hydroxychloroquine and ivermectin dispensed from Australian pharmacies increased significantly in 2020 as the Covid pandemic took hold, according to new research.Analysis of six publicly subsidised drugs – including hydroxychloroquine, ivermectin, corticosteroids and the common antibiotic azithromycin – found Covid-related changes in prescription patterns in Australia.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 30, 2021 Category: Science Authors: Donna Lu Tags: Health Coronavirus Drugs Medical research Australia news Source Type: news

Common antibiotic is NOT effective at preventing symptoms of COVID-19 in patients with mild cases 
Five COVID-19 patients being treated with azithromycin were hospitalized compared to no patients in the placebo group, a new study from the University of California, San Francisco found. (Source: the Mail online | Health)
Source: the Mail online | Health - July 19, 2021 Category: Consumer Health News Source Type: news

Azithromycin no more effective against COVID-19 than placebo: Study
The research, published in the Journal of the American Medical Association, included 263 participants who all tested positive for SARS-CoV-2, the virus which causes COVID-19, within seven days before entering the study. (Source: The Economic Times)
Source: The Economic Times - July 19, 2021 Category: Consumer Health News Source Type: news

COVID-19 rapid guideline: managing COVID-19 NICE guideline [NG191], (updated 3rd June 2021)
This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use them more easily 3 June 2021 new recommendations on azithromycin to treat COVID-19 added (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 16, 2021 Category: Consumer Health News Source Type: news

Common COVID-19 antibiotic no more effective than placebo
(University of California - San Francisco) A UC San Francisco study has found that the antibiotic azithromycin was no more effective than a placebo in preventing symptoms of COVID-19 among non-hospitalized patients, and may increase their chance of hospitalization, despite widespread prescription of the antibiotic for the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 16, 2021 Category: Infectious Diseases Source Type: news

Covid first wave led to increase in antibiotic misuse in India: Study
The researchers at Washington University in the US estimated that Covid-19 likely contributed to 216.4 million excess doses of antibiotics and 38 million more doses of azithromycin in adults from June 2020 through September 2020, a period of peak Covid-19 activity in India. (Source: The Economic Times)
Source: The Economic Times - July 2, 2021 Category: Consumer Health News Source Type: news